Classical Inhibitors of NOX NAD(P)H Oxidases Are Not Specific

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|9|8|686-696

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.9, Iss.8, 2008-01, pp. : 686-696

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases

By Cai H.   Griendling K.K.   Harrison D.G.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 9, 2003-09 ,pp. : 471-478

Elsevier

Access to resources Recommend Favorite

NAD(P)H: QUINONE OXIDOREDUCTASE POLYMORPHISM AND LUNG CANCER IN TAIWAN

By Lin Pinpin   Wang Hsiu-Jen   Lee Huei   Lee Hong-Shen   Wang Shu-Li   Hsueh Yu-Mei   Tsai Kan-Jen   Chen Chih-Yi  

Journal of Toxicology and Environmental Health, Vol. 58, Iss. 4, 1999-10 ,pp. : 187-197

Taylor & Francis Ltd

Access to resources Recommend Favorite

The interrelation of the angiotensin and endothelin systems on the modulation of NAD(P)H oxidase

By Laplante Marc-André   de Champlain Jacques  

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 1, 2006-01 ,pp. : 21-28

NRC Research Press

Access to resources Recommend Favorite

Rehab of NAD(P)-Dependent Enzymes with NAD(P)-Based Inhibitors

By  

Current Medicinal Chemistry, Vol. 18, Iss. 13, 2011-05 ,pp. : 1891-1908

Bentham Science Publishers

Access to resources Recommend Favorite

Biological and Clinical Significance of Polymorphisms in NAD(P)H: Quinone Oxidoreductase 1 (NQO1)

By  

Current Pharmacogenomics, Vol. 2, Iss. 1, 2004-03 ,pp. : 75-82

Bentham Science Publishers

Access to resources Recommend Favorite